![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Hepatitis |
Free Subscription
1 Arch Virol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hepatitis is free of charge.
miR-HCC2 suppresses hepatitis B virus replication by inhibiting the activity of
the enhancer I/X promoter.
Arch Virol. 2023;168:282.
PubMed
Abstract available
Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe
Alcoholic Hepatitis.
Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
PubMed
Abstract available
Which is more clinically relevant: end-of-treatment or off-treatment predictors
of hepatitis B relapse and surface antigen loss?
Gastroenterology. 2023 Oct 25:S0016-5085(23)05196.
PubMed
Reply: Cautious interpretation of the association between finite treatment and
better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis.
Hepatology. 2023 Oct 31. doi: 10.1097/HEP.0000000000000662.
PubMed
Letter to the Editor: Cautious interpretation of the association between finite
treatment and better prognosis in initially HBeAg-negative hepatitis B patients
with cirrhosis.
Hepatology. 2023 Oct 31. doi: 10.1097/HEP.0000000000000654.
PubMed
Hepatocellular carcinoma risk in Sub-Saharan African and Afro-Surinamese
individuals with chronic hepatitis B living in Europe.
J Hepatol. 2023 Oct 26:S0168-8278(23)05219-4. doi: 10.1016/j.jhep.2023.
PubMed
Abstract available
Molecular point of care testing for hepatitis C: available technologies, pipeline
and promising future directions.
J Infect Dis. 2023 Oct 28:jiad463. doi: 10.1093.
PubMed
Abstract available
Hepatitis A outbreak in a refugee shelter in Kiel, northern Germany.
J Med Virol. 2023;95:e29185.
PubMed
Abstract available
IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV
infection.
J Med Virol. 2023;95:e29142.
PubMed
Abstract available
Chronic hepatitis B beyond clinical burden: Psychosocial effects and impact on
quality of life.
J Viral Hepat. 2023 Nov 3. doi: 10.1111/jvh.13894.
PubMed
Abstract available
"There's too much power in this number. It's freaking the whole response out":
the views of key informants on evidence and targets to achieve hepatitis C
elimination goals in Australia.
J Viral Hepat. 2023 Nov 2. doi: 10.1111/jvh.13896.
PubMed
Abstract available
CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and
Children - United States, 2023.
MMWR Recomm Rep. 2023;72:1-21.
PubMed
Abstract available
Earlier Screening of Infants With Perinatal Hepatitis C Exposure: A Key Step
Towards Elimination.
Pediatrics. 2023 Nov 1. doi: 10.1542/peds.2023-064242.
PubMed
Abstract available
Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines
expressing hepatitis B virus surface antigen.
PLoS One. 2023;18:e0293167.
PubMed
Abstract available
Phenotype and fate of liver-resident CD8 T cells during acute and chronic
hepacivirus infection.
PLoS Pathog. 2023;19:e1011697.
PubMed
Abstract available
Omicron breakthrough infections in vaccinated or previously infected hamsters.
Proc Natl Acad Sci U S A. 2023;120:e2308655120.
PubMed
Abstract available
Thank you for your interest in scientific medicine.